Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

Slide: 12 of 35

Clinically Important Outcomes of Interest in the Comparative Effectiveness Review (2 of 3)

For assessing schizophrenia, positive symptoms were often evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Scale for the Assessment of Positive Symptoms (SAPS). Negative symptoms were often evaluated with the PANSS and the Scale for the Assessment of Negative Symptoms (SANS). General psychopathology was assessed with the Agitated Behavior Scale (ABS), the Agitation-Calmness Evaluation Scale (ACES), the Calgary Depression Scale for Schizophrenia (CDS-S), the Hamilton Anxiety Scale (HAM-A), the Hamilton Depression Scale (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), and the PANSS. Global ratings and total scores were reported using the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impressions–Improvement Subscale (CGI-I), the CGI–Severity Subscale (CGI-S), and the PANSS.